Skip to content

Author

Hyun Ho Park

We have 6 of 43 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Diverse routes to Cas3 activation in type I CRISPR-Cas immunity.

Jiang et al. show that the type I-A CRISPR system of Saccharolobus islandicus recruits Cas3 only after target recognition. Their study reveals different Cas3 activation mechanisms and a dual role of ATP in target degradation and collateral cleavage.

Hyun Ho Park · 0 citations
Open access Sep 2026

Immunogenic Cell Death Induced by EEO in Breast Cancer Cells Promotes Dendritic Cell Activation in a CRT-Dependent Manner

Cancer immunotherapy faces significant challenges in treating “cold” tumors, which respond poorly to current strategies. Breast cancer is a major cause of cancer-related mortality in women and is a representative immunosuppressive cold tumor. The luminal A subtype of breast cancer exhibits an immune-cold phenotype, wit...

Seong-Ah Shin, Sun-Young Moon, Seyeon Choi et al. · 0 citations
Review Open access Sep 2026

The Relationship Between Immunogenic Cell Death and Cellular Senescence in Cancer Immunotherapy

Evidence that agents capable of inducing ICD may instead promote cellular senescence when administered at lower concentrations for prolonged periods is highlighted, indicating that these distinct cellular outcomes can be determined by drug dose and treatment duration.

Seong-Ah Shin, Minji Kim, Moonsu Kim et al. · 0 citations
Open access Jul 2026

An expanded realm of anti-CRISPR-associated proteins and regulatory mechanisms

It is shown that Aca14, newly identified in this study, represses two predicted anti-defence operons and is a ribbon-helix-helix domain protein, revealing regulatory diversity beyond the canonical HTH Aca family members.

Maximilian Feussner, N. Birkholz, So-Ye-On Lee et al. · 0 citations
#protein folding Open access Aug 2026

Structural insights into Cas9 inhibition by AcrIIA17 via bridge helix interaction

The crystal structure of AcrIIA17 is presented and its mechanism of Staphylococcus aureus Cas9 (SauCas9) inhibition is elucidated, identifying AcrIIA17 as an Acr protein that targets the Cas9 BH domain and reveal the BH domain as a regulatory checkpoint in Cas9 activation.

G. Kim, Hyo Been Jin, Yong-Jun Kang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.